Trial Condition(s):

Transcatheter Aortic Valve Replacement

Global study comparing a rivAroxaban-based antithrombotic strategy to an antipLatelet-based strategy after transcatheter aortIc vaLve rEplacement to Optimize clinical outcomes (GALILEO)

Bayer Identifier:

17938

ClinicalTrials.gov Identifier:

NCT02556203

EudraCT Number:

2015-001975-30

EU CT Number:

Not Available

Terminated/Withdrawn

Trial Purpose

To assess whether a rivaroxaban-based anticoagulation strategy, following successful TAVR, compared to an antiplatelet-based strategy, is superior in reducing death or first thromboembolic events (DTE).
To assess the primary bleeding events (PBE) of the rivaroxaban-based strategy compared to an antiplatelet-based strategy, following TAVR.

Inclusion Criteria
- Successful TAVR (Transcatheter Aortic Valve Replacement) of an aortic valve stenosis (either native
or valve-in-valve)
 -- By iliofemoral or subclavian access
 -- With any approved/marketed device
Exclusion Criteria
- Atrial fibrillation (AF), current or previous, with an ongoing indication for oral anticoagulant treatment
 - Any other indication for continued treatment with any oral anticoagulant (OAC)
 - Known bleeding diathesis (such as but not limited to active internal bleeding, clinically significant bleeding, platelet count ≤ 50,000/mm3 at screening, hemoglobin level < 8.5 g/dL, active peptic ulcer or known gastrointestinal (GI) bleeding, history of intracranial hemorrhage or subdural hematoma)
 - Any ongoing absolute indication for dual antiplatelet therapy (DAPT) at time of screening that is unrelated to the TAVR procedure
 - Clinically overt stroke within the last 3 months
 - Planned coronary or vascular intervention or major surgery
 - Severe renal impairment (eGFR < 30 mL/min/1.73 m2) or on dialysis, or post-TAVR unresolved acute kidney injury with renal dysfunction stage 2 or higher
 - Moderate and severe hepatic impairment (Child-Pugh Class B or C) or any hepatic disease associated with coagulopathy

Trial Summary

Enrollment Goal
1653
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Locations
Locations

Investigative Site

Graz, Austria, 8036

Locations

Investigative Site

Wien, Austria, 1090

Locations

Investigative Site

Wien, Austria, 1130

Locations

Investigative Site

Wels, Austria, 4600

Locations

Investigative Site

Salzburg, Austria, 5020

Locations

Investigative Site

Linz, Austria, 4020

Locations

Investigative Site

Brno, Czech Republic, 656 91

Locations

Investigative Site

Bad Nauheim, Germany, 61231

Locations

Investigative Site

Bad Berka, Germany, 99437

Locations

Investigative Site

Bad Neustadt, Germany, 97616

Locations

Investigative Site

Bad Segeberg, Germany, 23795

Locations

Investigative Site

Erlangen, Germany, 91054

Locations

Investigative Site

Berlin, Germany, 10117

Locations

Investigative Site

Magdeburg, Germany, 39120

Locations

Investigative Site

Mainz, Germany, 55131

Locations

Investigative Site

Regensburg, Germany, 93042

Locations

Investigative Site

Bonn, Germany, 53105

Locations

Investigative Site

Köln, Germany, 50924

Locations

Investigative Site

Lahr, Germany, 77033

Locations

Investigative Site

München, Germany, 80331

Locations

Investigative Site

Rotenburg a.d. Fulda, Germany, 36199

Locations

Investigative Site

Tübingen, Germany, 72076

Locations

Investigative Site

Berlin, Germany, 12200

Locations

Investigative Site

Bern, Switzerland, 3010

Locations

Investigative Site

Basel, Switzerland, 4056

Locations

Investigative Site

Luzern, Switzerland, 6000

Locations

Investigative Site

Zürich, Switzerland, 8091

Locations

Investigative Site

Madrid, Spain, 28046

Locations

Investigative Site

Oviedo, Spain, 33011

Locations

Investigative Site

Málaga, Spain, 29010

Locations

Investigative Site

Barcelona, Spain, 08036

Locations

Investigative Site

L'Hospitalet de Llobregat, Spain, 08907

Locations

Investigative Site

Berlin, Germany, 13353

Locations

Investigative Site

Düsseldorf, Germany, 40225

Locations

Investigative Site

Hamburg, Germany, 20246

Locations

Investigative Site

Hannover, Germany, 30625

Locations

Investigative Site

Neuss, Germany, 41464

Locations

Investigative Site

Fulda, Germany, 36043

Locations

Investigative Site

BREST, France, 29609

Locations

Investigative Site

Praha 10, Czech Republic, 10034

Locations

Investigative Site

Praha 4, Czech Republic, 140 21

Locations

Investigative Site

Bielsko-Biala, Poland, 43-316

Locations

Investigative Site

Warszawa, Poland, 04-628

Locations

Investigative Site

Warszawa, Poland, 02-097

Locations

Investigative Site

Brighton, United Kingdom, BN2 5BE

Locations

Investigative Site

Leeds, United Kingdom, LS1 3EX

Locations

Investigative Site

Leicester, United Kingdom, LE3 9QP

Locations

Investigative Site

London, United Kingdom, SE1 7EH

Locations

Investigative Site

Belfast, United Kingdom, BT12 6BA

Locations

Investigative Site

Edinburgh, United Kingdom, EH16 4SA

Locations

Investigative Site

Blackpool, United Kingdom, FY3 8NR

Locations

Investigative Site

Wien, Austria, 1160

Locations

Investigative Site

Krefeld, Germany, 47805

Locations

Investigative Site

Freiburg, Germany, 79106

Locations

Investigative Site

Leipzig, Germany, 04289

Locations

Investigative Site

Kiel, Germany, 24105

Locations

Investigative Site

New York, United States, 10029

Locations

Investigative Site

Catania, Italy, 95124

Locations

Investigative Site

Milano, Italy, 20162

Locations

Investigative Site

Charlottesville, United States, 22908

Locations

Investigative Site

Philadelphia, United States, 19104

Locations

Investigative Site

Plano, United States, 75093

Locations

Investigative Site

Chicago, United States, 60611

Locations

Investigative Site

Baltimore, United States, 21201

Locations

Investigative Site

Burlington, United States, 05401

Locations

Investigative Site

Kansas City, United States, 64111

Locations

Investigative Site

LIEGE, Belgium, 4000

Locations

Investigative Site

HASSELT, Belgium, 3500

Locations

Investigative Site

GENK, Belgium, 3600

Locations

Investigative Site

Bergamo, Italy, 24127

Locations

Investigative Site

Milano, Italy, 20089

Locations

Investigative Site

Padova, Italy, 35128

Locations

Investigative Site

Milano, Italy, 20132

Locations

Investigative Site

Pisa, Italy, 56124

Locations

Investigative Site

Winston-Salem, United States, 27157-1082

Locations

Investigative Site

Evanston, United States, 60201

Locations

Investigative Site

Roslyn, United States, 11576

Locations

Investigative Site

Houston, United States, 77030-1501

Locations

Investigative Site

Southampton, United Kingdom, SO16 6YD

Locations

Investigative Site

Newcastle Upon Tyne, United Kingdom, NE7 7DN

Locations

Investigative Site

Oxford, United Kingdom, OX9 3DU

Locations

Investigative Site

London, United Kingdom, SE5 9RS

Locations

Investigative Site

AMSTERDAM, Netherlands, 1105 AZ

Locations

Investigative Site

ROTTERDAM, Netherlands, 3015 CE

Locations

Investigative Site

BREDA, Netherlands, 4818 CK

Locations

Investigative Site

Copenhagen, Denmark, DK-2100

Locations

Investigative Site

Odense C, Denmark, DK-5000

Locations

Investigative Site

Oslo, Norway, 0424

Locations

Investigative Site

Tromsø, Norway, 9038

Locations

Investigative Site

Bergen, Norway, N-5021

Locations

Investigative Site

TOULOUSE, France, 31300

Locations

Investigative Site

Chambray-lès-Tours, France, 37170

Locations

Investigative Site

Angers, France, 49100

Locations

Investigative Site

LILLE, France, 59000

Locations

Investigative Site

Uppsala, Sweden, 751 85

Locations

Investigative Site

Newmarket, Canada, L3Y 2P7

Locations

Investigative Site

Edmonton, Canada, T6G 2B7

Locations

Investigative Site

Toronto, Canada, M5G 2C4

Locations

Investigative Site

Vancouver, Canada, V6A 1Y6

Locations

Investigative Site

Victoria, Canada, V8R 4R2

Locations

Investigative Site

Seoul, South Korea, 06351

Locations

Investigative Site

Seoul, South Korea, 110-744

Locations

Investigative Site

Seoul, South Korea, 06591

Locations

Investigative Site

Seoul, South Korea, 120-752

Locations

Investigative Site

Houston, United States, 77030

Locations

Investigative Site

Washington, United States, 20010

Locations

Investigative Site

Cincinnati, United States, 45219

Locations

Investigative Site

Detroit, United States, 48202

Locations

Investigative Site

Miami, United States, 33136

Locations

Investigative Site

Clearwater, United States, 33756

Locations

Investigative Site

Atlanta, United States, 30322

Locations

Investigative Site

Wilkes-Barre, United States, 18711-3752

Locations

Investigative Site

Manhasset, United States, 11030-3876

Locations

Investigative Site

Los Angeles, United States, 90048-0750

Locations

Investigative Site

Minneapolis, United States, 55407

Locations

Investigative Site

München, Germany, 81925

Locations

Investigative Site

Frankfurt, Germany, 60389

Locations

Investigative Site

Dortmund, Germany, 44137

Locations

Investigative Site

Halifax, Canada, B3H 3A7

Locations

Investigative Site

Toronto, Canada, M4N 3M5

Locations

Investigative Site

Cleveland, United States, 44195

Locations

Investigative Site

Morristown, United States, 07962

Locations

Investigative Site

Montreal, Canada, H1T 1C8

Locations

Investigative Site

Aachen, Germany, 52074

Locations

Investigative Site

Ulm, Germany, 89081

Locations

Investigative Site

Boston, United States, 02215

Locations

Investigative Site

Winnipeg, Canada, R2H 2A6

Locations

Investigative Site

Jacksonville, United States, 32209

Locations

Investigative Site

Aarhus N, Denmark, 8200

Locations

Investigative Site

Homburg, Germany, 66424

Locations

Investigative Site

Konstanz, Germany, 78464

Locations

Investigative Site

Tacoma, United States, 98405

Locations

Investigative Site

Temple, United States, 76508

Locations

Investigative Site

West Des Moines, United States, 50266

Locations

Investigative Site

Falls Church, United States, 22042-3300

Locations

Investigative Site

München, Germany, 80636

Locations

Investigative Site

Lugano, Switzerland, 6900

Locations

Investigative Site

Bremen, Germany, 28277

Locations

Investigative Site

PARIS, France, 75014

Locations

Investigative Site

Paris, France, 75018

Trial Design